|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
12/14/23 Tourmaline Bio, Inc. 8-K:5,7,9 12/13/23 11:288K
11/30/23 Tourmaline Bio, Inc. 8-K:5 11/29/23 10:151K
10/27/23 Tourmaline Bio, Inc. 8-K:5,9 10/23/23 12:311K Donnelley … Solutions/FA
10/20/23‡ Tourmaline Bio, Inc. 8-K:1,2,3,510/19/23 24:863K Donnelley … Solutions/FA
6/22/23 Talaris Therapeutics, Inc. 8-K:1,5,7,9 6/22/23 16:13M Donnelley … Solutions/FA
5/30/23 Talaris Therapeutics, Inc. 8-K:5,8,9 5/26/23 11:208K Donnelley … Solutions/FA
4/14/23 Talaris Therapeutics, Inc. 8-K:2,5,9 4/14/23 11:213K Donnelley … Solutions/FA
5/17/22 Talaris Therapeutics, Inc. 8-K:5,7,9 5/13/22 11:161K Donnelley … Solutions/FA
____________ | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | ¹ | Filing/Form Type: | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. |
|